Furthermore, since it appears at the outset that allowing the regulated sale of organs would increase their supply to those who desperately needed them, the onus of proof must be with those who oppose this position to demonstrate why a worldwide ban should be maintained. The Kantian argument that selling a body part is degrading does not always apply, as degradation very much depends on one's own perception of what is degrading. And the very familiar slippery slope arguments, were they to form the basis of public policy, would exclude almost every public activity that had the slightest risk (driving, scuba diving, nuclear reactors). We cope because we regulate.
Medical professionals accept autonomy as a major bioethical principle, but are repulsed by the autonomous wish of the donor of a kidney to obtain money, resulting in what we have called the "autonomy paradox",9 even when the money is needed for purely altruistic reasons, for example to buy medication to save the life of a beloved daughter. John Dossetor6 has argued very effectively that the burden-benefit equation in these "indirect atruism" circumstances would justify allowing such payments, at least in those cultures where this would be acceptable and under circumstances where the alternatives for potential recipients would be death because dialysis was not available. A woman in the US recently offered to sell a kidney to pay for a laparoscopic cholecystectomy; she found this to be against the law. The bigger question here is the morality of legislation that bars a life-saving option for an individual while failing to provide societal relief. If it is moral to allow 20% of your population to have no medical insurance because your society is based on free markets and rugged individualism, and damn those who are incapable, surely such a society would value a presumption for autonomy in decisions on how best to find remedy?
Whiff of hypocrisy
There is also a whiff of hypocrisy about the profession's attitude to the subject. In a recent article'0 I proposed a ten-point charter meant to increase living renal donation generally. Half in jest I included a point which suggested that transplant teams should be the first to encourage altruism by forgoing part of their usual fees. I was only partly surprised at the number of letters I received objecting to that particular point while agreeing with the other nine. Dickens" has wondered why when hospitals, laboratories, pharmaceutical companies, physicians, surgeons etc, financially benefit from transplantation, it is only from the donor that we demand unmitigated altruism, which manifestly fails to distinguish donor from vendor anyway.7 Childress, in The subject is obviously much more complex than would appear at the outset. How, then, does one approach it? We have introduced a classification'3-'" based on the (much misunderstood) concept of gifting. The aim was to clarify the issues, accept and reject the obvious early in the discourse, and focus on the contentious. For living kidney donors, the categories were 1) living (genetically) related donors; 2) living (emotionally) related donors; 3) donation by altruistic strangers (is there a good reason why not?); 4) the Grey Basket; 5) rampant commercialism (no checks, balances, and including exploitation by middlemen) 6) criminally coerced procurement. It seems to me that categories 1-3 are easily acceptable, while 5 and 6 are not. This allows us, then, to concentrate on the Grey Basket concept, which would admit any principle-based idea to critical scrutiny. It might contain ideas such as the Donors' Trust,5 whereby there are societal/ professional mechanisms to separate payments from treatment, and available funds to ensure equal access. Francis Moore hinted at something like this when he said that "selling of kidneys from living donors, evidently a common practice in India, finds a negative response in our society unless the recipients are chosen without respect to ability to pay, ie some form of government subsidy""5; or, there are Dossetor's ideas, which take into account cultural and economic realities and which refer to "indirect altruism" and "mandated philanthropy".'
What is perhaps surprising is that paid organ donation is not more common than it actually is. Ask any economist and you will learn that the combination of demand, scarcity and need automatically equals a black market. As sustainable arguments for the ban there will be increasing pressure to consider a scientifically valid trial of paid donation under controlled conditions whereby the interests of all parties concerned are looked after, abuse is minimised, and access is guaranteed to both the rich and the poor. Ironically, such a trial will need to be performed in a country where the rule of law is respected, the likelihood of corruption minimal, and transparency is guaranteed24. It is just possible that under these conditions the abuse we currently see will be eliminated.
